ClinicalTrials.Veeva

Menu

Untreated Sleep Apnea as an Aggravating Factor for Other Secondary Medical Conditions After Spinal Cord Injury

University Health Network, Toronto logo

University Health Network, Toronto

Status

Completed

Conditions

Spasticity, Muscle
Spinal Cord Injuries
Cardiovascular Complication
Neuropathic Pain
Sleep Apnea

Treatments

Device: Home-based sleep screening test or hospital-unattended sleep screening test
Device: Cardiovascular beat-to-beat monitoring
Device: ECG monitoring

Study type

Observational

Funder types

Other

Identifiers

NCT05687097
19-5285

Details and patient eligibility

About

This cross-sectional prospective study will assess the potential association of more severe sleep apnea after spinal cord injury with more intense neuropathic pain, more severe spasticity, and more significant cardiovascular abnormalities including cardiac arrhythmias and blood pressure fluctuations. In addition, the participants' experience when undergoing home-based sleep screening test or hospital-unattended sleep screening test will be assessed in a semi-structured interview.

Full description

This cross-sectional prospective study will assess the potential association of more severe sleep apnea after spinal cord injury with more intense neuropathic pain, more severe spasticity, and more significant cardiovascular abnormalities including cardiac arrhythmias and blood pressure fluctuations. In addition, the participants' experience when undergoing home-based sleep screening test or hospital-unattended sleep screening test will be assessed in a semi-structured interview (qualitative analysis).

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Individuals with subacute/chronic (> 1 month after injury) spinal cord injury.
  • Individuals with a mid-cervical/mid-thoracic (levels C5 to T6) spinal cord injury.
  • Individuals with a complete or incomplete (ASIA Impairment Scale A, B, C, or D) spinal cord injury.

Exclusion criteria

  • individuals with other disorders of the central nervous system (e.g., sequelae of traumatic brain injury, stroke);
  • Individuals with psychiatric disorders that can interfere with adherence to study;
  • Individuals with neuromuscular diseases;
  • Individuals with history of substance abuse;
  • Individuals with prior history of hypersomnias or sleep apnea under treatment;
  • Individuals with prior history of chronic pain (e.g. fibromyalgia).

Trial design

60 participants in 4 patient groups

Individuals without sleep apnea after spinal cord injury
Description:
No significant sleep apnea is defined as an apnea-hypopnea index (AHI) \< 5 events per hour of sleep
Treatment:
Device: ECG monitoring
Device: Cardiovascular beat-to-beat monitoring
Device: Home-based sleep screening test or hospital-unattended sleep screening test
Individuals with mild sleep apnea after spinal cord injury
Description:
Mild sleep apnea is defined as an apnea-hypopnea index (AHI) ≥ 5 events per hour of sleep, but an AHI \<15 events.
Treatment:
Device: ECG monitoring
Device: Cardiovascular beat-to-beat monitoring
Device: Home-based sleep screening test or hospital-unattended sleep screening test
Individuals with moderate sleep apnea after spinal cord injury
Description:
Mild sleep apnea is defined as an apnea-hypopnea index (AHI) ≥ 5 events per hour of sleep but an AHI \<15 events.
Treatment:
Device: ECG monitoring
Device: Cardiovascular beat-to-beat monitoring
Device: Home-based sleep screening test or hospital-unattended sleep screening test
Individuals with severe sleep apnea after spinal cord injury
Description:
Severe sleep apnea is defined as an apnea-hypopnea index (AHI) \> 30 events per hour of sleep.
Treatment:
Device: ECG monitoring
Device: Cardiovascular beat-to-beat monitoring
Device: Home-based sleep screening test or hospital-unattended sleep screening test

Trial contacts and locations

1

Loading...

Central trial contact

Mitsue Aibe, MD; Abrity Gomes

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems